Sign inJoin waitlistJoin the waitlist

Sailaja Kamaraju

Professor · Medical College of Wisconsin Affiliated Hospitals, Inc

Credentials: · · ·

History

Medical College of Wisconsin Affiliated Hospitals, Inc
Present

Hematology and Medical Oncology
University of Minnesota
1999–2002
Internal Medicine
Hennepin Healthcare
1996–1999
Guntur Medical College, Guntur
1988–1992

Research

Motility response to insulin-like growth factor-I (IGF-I) in MCF-7 cells is associated with IRS-2 activation and integrin expression
Breast Cancer Research and Treatment · 2004 · 45 citations
The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees
Journal of the National Cancer Institute · 2015 · 41 citations
Cancer Prevention in Low-Resource Countries: An Overview of the Opportunity
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2020 · First of 4 authors · 35 citations

Lubna Chaudhary
11 papers
Chandler Cortina
9 papers
Joan Neuner
9 papers · 2 as a resident
Yee Cheng
9 papers
Christopher Chitambar
7 papers
Julie Jorns
6 papers
Amanda Kong
5 papers
John Burfeind
5 papers
Meghan Conroy
5 papers · 5 as a resident
Caitlin Patten
3 papers
Carmen Bergom
3 papers
Heun Min
3 papers · 3 as a resident

Clinical trials

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
Principal investigator · Recruiting
Medical College of Wisconsin
2024–2027
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
Study chair · Terminated · Phase 2
University of Wisconsin, Madison
2021–2023
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2032